In patients with rheumatoid arthritis, rituximab significantly reduced serum concentrations of CRP, RF, anti-CCP, IL-2, IL-6, IL-7, IL-10, and ESR [63]. The gene discussed is IL2; the disease is rheumatoid arthritis.